the r&d approaches at amgen & cullinan oncology
Published 4 months ago • 29 plays • Length 8:41Download video MP4
Download video MP3
Similar videos
-
6:05
driving efficiency from r&d to the clinic
-
11:01
challenges to greenlighting biologics r&d
-
12:07
best bets for biopharma r&d efficiency
-
5:26
what biopharma r&d steps are ripe for efficiency gains?
-
7:36
faster biopharma r&d: what could go wrong?
-
10:25
there is a new hope for als!
-
1:59
rtds technologies | ametek connect
-
12:13
the autonomic nervous system: the ligands and receptors 🐧
-
11:42
countdown to patient impact: how fast can we go?
-
9:21
ai & creativity in molecular design and target id
-
15:26
content from amgen oncology: accelerating discovery
-
42:54
amgen r&d / academic strategies
-
6:39
coas and dhts and post-approval monitoring
-
1:45
amgen’s research & development (r&d) vision
-
5:34
aav-mediated inclusion formation as a novel gene therapy strategy for als
-
14:23
cartherics
-
22:21
2018-05 - turk - imaging advances in amn: spinal cord
-
28:18
the near-term future of exosome science with capricor therapeutics' dr. linda marbán
-
12:35
aacr 2018: seamlessly integrate single-cell genomics into your ngs workflow
-
5:28
dr. markus rossi, head of innovation, ams ag
-
1:13
emmanuel apor, md – atlantic medical group